Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Neoplasms of the CNS

Free Subscription 08.04.2024 1 Brain 4 Clin Cancer Res 1 Int J Radiat Oncol Biol Phys 7 J Neurooncol 8 J Neurosurg 5 Neuro Oncol 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Brain

1. HERBET G, Duffau H, Mandonnet E
   Predictors of cognition after glioma surgery: connectotomy, structure-function phenotype, plasticity.
   Brain. 2024 Apr 4:awae093. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

2. HANSFORD JR, Das A, McGee RB, Nakano Y, et al
   Update on cancer predisposition syndromes and surveillance guidelines for childhood brain tumors.
   Clin Cancer Res. 2024 Apr 4. doi: 10.1158/1078-0432.CCR-23-4033.
   PubMed         Abstract available
   
   
3. CICCONE R, Quintarelli C, Camera A, Pezzella M, et al
   GD2-targeting CAR T-cell therapy for patients with GD2+ medulloblastoma.
   Clin Cancer Res. 2024 Mar 29. doi: 10.1158/1078-0432.CCR-23-1880.
   PubMed         Abstract available
   
   
4. LYNCE F, Lin NU
   From Serendipity to Intention: Development of Brain-Penetrant PARP1-Selective Inhibitors.
   Clin Cancer Res. 2024;30:1217-1219.
   PubMed         Abstract available
   
   
5. STANISZEWSKA AD, Pilger D, Gill SJ, Jamal K, et al
   Preclinical Characterization of AZD9574, a Blood-Brain Barrier Penetrant Inhibitor of PARP1.
   Clin Cancer Res. 2024;30:1338-1351.
   PubMed         Abstract available
   
   

   
   Int J Radiat Oncol Biol Phys

6. ONG WL, Stewart J, Sahgal A, Soliman H, et al
   Predictors of tumour dynamics over a 6-week course of concurrent chemoradiotherapy for glioblastoma and the impact on survival.
   Int J Radiat Oncol Biol Phys. 2024 Mar 30:S0360-3016(24)00453.
   PubMed         Abstract available
   
   

   
   J Neurooncol

7. TONG E, Horsley P, Wheeler H, Wong M, et al
   Hypofractionated re-irradiation with bevacizumab for relapsed chemorefractory glioblastoma after prior high dose radiotherapy: a feasible option for patients with large-volume relapse.
   J Neurooncol. 2024 Mar 29. doi: 10.1007/s11060-024-04643.
   PubMed         Abstract available
   
   
8. JOST J, Volker K, Brandt R, Stummer W, et al
   Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness status.
   J Neurooncol. 2024 Apr 1. doi: 10.1007/s11060-024-04629.
   PubMed         Abstract available
   
   
9. XIANG Y, Chen Y, Xu Z, Zhou S, et al
   Real-world cost- effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China.
   J Neurooncol. 2024 Apr 2. doi: 10.1007/s11060-024-04662.
   PubMed         Abstract available
   
   
10. LU VM, Brun JD, Niazi TN, Brun JD, et al
    Pediatric neurosurgical medulloblastoma outcomes in La Paz, Bolivia: How a Lower Middle-Income Country (LMIC) institution in South America compares to the United States.
    J Neurooncol. 2024 Apr 2. doi: 10.1007/s11060-024-04664.
    PubMed         Abstract available
    
    
11. DMUKAUSKAS M, Cioffi G, Waite KA, Sloan AE, et al
    Sex differences in adverse events in Medicare individuals >/= 66 years of age post glioblastoma treatment.
    J Neurooncol. 2024 Apr 2. doi: 10.1007/s11060-024-04652.
    PubMed         Abstract available
    
    
12. MAHMOODIFAR S, Pangal DJ, Neman J, Zada G, et al
    Comparative analysis of the spatial distribution of brain metastases across several primary cancers using machine learning and deep learning models.
    J Neurooncol. 2024 Apr 2. doi: 10.1007/s11060-024-04630.
    PubMed         Abstract available
    
    
13. MIRZAYEVA L, Ucar M, Kaymaz AM, Temel E, et al
    Intraoperative magnetic resonance imaging in glioma surgery: a single-center experience.
    J Neurooncol. 2024 Apr 3. doi: 10.1007/s11060-024-04660.
    PubMed         Abstract available
    
    

    
    J Neurosurg

14. ZHANG S, Yao S, Chen J, Akter F, et al
    Correlation between tumor invasion and somatostatin receptor subtypes in acromegaly.
    J Neurosurg. 2023;140:1019-1028.
    PubMed         Abstract available
    
    
15. LUCIDO T, Rajkumar S, Rogowski B, Meinert J, et al
    The 5-factor modified frailty index as a prognostic factor of stereotactic radiosurgery for metastatic disease to the brain.
    J Neurosurg. 2023;140:929-937.
    PubMed         Abstract available
    
    
16. VAZQUEZ S, Gold J, Spirollari E, Akmal S, et al
    The story of dexamethasone and how it became one of the most widely used drugs in neurosurgery.
    J Neurosurg. 2023 Nov 24:1-7. doi: 10.3171/2023.9.JNS231099.
    PubMed         Abstract available
    
    
17. REN L, Xie Q, Deng J, Chen J, et al
    Association of frequent NF2 mutations with spinal location predominance and worse outcomes in psammomatous meningiomas.
    J Neurosurg. 2024 Mar 29:1-9. doi: 10.3171/2024.1.JNS232450.
    PubMed         Abstract available
    
    
18. KONECNA D, Vymola P, Ternerova N, Vymolova B, et al
    Molecularly targeted protease-activated probes for visualization of glioblastoma: a comparison with 5-ALA.
    J Neurosurg. 2024 Mar 29:1-12. doi: 10.3171/2024.1.JNS231137.
    PubMed         Abstract available
    
    
19. MAKARENKO S
    Erratum. Grade 3 meningioma survival and recurrence outcomes in an international multicenter cohort.
    J Neurosurg. 2024 Mar 29:1. doi: 10.3171/2024.2.JNS23465.
    PubMed        
    
    
20. MERENZON MA, Mendez Valdez MJ, Chandar J, Lu VM, et al
    Minimally invasive keyhole approach for supramaximal frontal glioma resections: technical note.
    J Neurosurg. 2023;140:949-957.
    PubMed         Abstract available
    
    
21. ASFAW ZK, Hernandez-Marquez GC, Naik A, Young T, et al
    The intersection of race and social determinants of health on clinical outcome of glioblastoma patients.
    J Neurosurg. 2024 Apr 5:1-10. doi: 10.3171/2024.1.JNS232702.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

22. OBRECHT-STURM D, Schomig L, Mynarek M, Bison B, et al
    Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent MRI lesions after first-line treatment.
    Neuro Oncol. 2024 Apr 5:noae071. doi: 10.1093.
    PubMed         Abstract available
    
    
23. RICKLEFS FL, Wollmann K, Salviano-Silva A, Drexler R, et al
    Circulating extracellular vesicles as biomarker for diagnosis, prognosis and monitoring in glioblastoma patients.
    Neuro Oncol. 2024 Apr 3:noae068. doi: 10.1093.
    PubMed         Abstract available
    
    
24. XIE H, Jiang Y, Xiang Y, Wu B, et al
    Super-enhancer-driven LIF promotes the mesenchymal transition in glioblastoma by activating ITGB2 signaling feedback in microglia.
    Neuro Oncol. 2024 Mar 30:noae065. doi: 10.1093.
    PubMed         Abstract available
    
    
25. DE LA NAVA D, Ausejo-Mauleon I, Laspidea V, Gonzalez-Huarriz M, et al
    The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models.
    Neuro Oncol. 2024 Mar 30:noae066. doi: 10.1093.
    PubMed         Abstract available
    
    
26. IVANIDZE J, Chang SJ, Haghdel A, Kim JT, et al
    [Ga68] DOTATATE PET/MRI-Guided Radiosurgical Treatment Planning and Response Assessment in Meningiomas.
    Neuro Oncol. 2024 Mar 30:noae067. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    PLoS One

27. SUN B, Lu W, Yu W, Tian Y, et al
    Prevalence and risk factors of early postoperative seizures in patients with glioma: A protocol for meta-analysis and systematic review.
    PLoS One. 2024;19:e0301443.
    PubMed         Abstract available
    
    
28. WANG L, Wang H, D'Angelo F, Curtin L, et al
    Quantifying intra-tumoral genetic heterogeneity of glioblastoma toward precision medicine using MRI and a data-inclusive machine learning algorithm.
    PLoS One. 2024;19:e0299267.
    PubMed         Abstract available
    
    
29. JAMBOR I, Steiner A, Pesola M, Gardberg M, et al
    Relaxation Along a Fictitious Field, continuous wave T1rho, adiabatic T1rho and adiabatic T2rho imaging of human gliomas at 3T: A feasibility study.
    PLoS One. 2024;19:e0296958.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.